Life Science Filtration Global Market - Forecast To 2028

Filtration is a process designed to remove particles and microorganisms from the liquids and gases and also protect the ingredients from environmental contaminants using porous media. The process is widely adopted in life science industries (Pharmaceutical & biopharmaceutical, research and medical device) for multiple applications in drug discovery development & manufacturing, medical treatments and research. The systems, consumables (filters) and accessories are necessary to perform filtration process. The filters of different pore size (micro, ultra, and nano); designs (pleated, hollow fiber, lenticular, flat sheets) and formats (cylindrical cartridge, capsules, discs, cassettes, syringe and vacuum filters) are available for various applications. Effective filtration area, pore size, flow rate, design, and formats are the factors should be considered, while selecting right filter for use in various applications in pharma and biopharma, medical and research as it makes a huge difference in yields, process economics and product viability.

The life science filtration global market is expected to grow at a double digit CAGR from 2021 to 2028 to reach $23,684.5 million by 2028. The factors such as growing demand for biologics, increasing investment in research and development (R&D) and expansion of manufacturing facilities, demand for generic pharmaceuticals, rapid growth of medtech industry with increasing disease population are driving the market, Whereas increasing use of single use technologies and advancements in filtration technologies such as  development of high capacity membrane filters, changes in designs of filters, advancement in membrane technologies and TFF process technologies are providing immense growth opportunities to the market. The high cost of filtration devices, complications associated with filtration and stringent regulations associated with pharma manufacturing and medical device industry are hindering the market growth.

The life science filtration global market is classified based on products, application, end-users and geography. Based on the products, the market is segmented into filtration systems, consumables and accessories. Among products, filtration consumables segment accounted for the highest revenue in 2021 and is expected to grow at a double digit CAGR from 2021 to 2028. The consumables market further segmented based on filter type and filter usage. Based on filter type, the consumables market is segmented into membrane filters and depth filters. Among the filter type, membrane filters segment accounted for the highest revenue in 2021 and is expected to grow at a double digit CAGR from 2021 to 2028. The membrane filters is further segmented based on technology into microfiltration, ultrafiltration and others. Among these, ultrafiltration segment accounted for the highest revenue in 2021 and is expected to grow at a double digit CAGR from 2021 to 2028. Microfiltration is expected to grow at a low teen CAGR from 2021 to 2028. Based on filter Usage, consumables market is further segmented into reusable filtration and single use filtration. Among these, reusable filtration is accounted for the highest revenue in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028. Single-Use filtration is expected to grow at a low teen CAGR from 2021 to 2028. The filtration systems global market is further segmented into Direct Flow System (DFF), Tangential Flow System (TFF) and others. Among these, Direct Flow System (DFF) segment accounted for the highest revenue in 2021 and is expected to grow at a high single digit CAGR from 2021 to 2028. Tangential Flow System (TFF) is expected to grow at a double digit CAGR from 2021 to 2028.

Based on applications the life science filtration global market is divided into drug discovery, development and manufacturing, final processing, medical device and others. Among the applications, drug discovery, development and manufacturing, accounted for the highest revenue in 2021 and is expected to grow at a low teen CAGR from 2021 to 2028. Drug discovery, development and manufacturing segment is further segmented based on molecule into small molecule filtration and large molecule filtration. Among these, large molecule filtration segment is accounted for the highest revenue in 2021 and is expected to grow at a mid teen CAGR from 2021 to 2028.

Based on end users, life science filtration market is segmented into Pharma, Biotech and CMO’s, Hospitals, Diagnostic labs & Dialysis centers and others. Among these, Pharma, Biotech and CMO’s segment is accounted for the highest revenue in 2021 and is expected to grow at a low teen CAGR from 2021 to 2028.

Based on geography, the life science filtration global market is segmented into North America, Europe, Asia-Pacific and the Rest of the world. North America accounted for the largest revenue in 2021 and is expected to grow at double digit CAGR from 2021 to 2028. Asia-Pacific is expected to grow at a double digit CAGR from 2021 to 2028 to reach $xx million by 2028.

Technological advancements are making life science filtration market more attractive. The development of high capacity membrane filters; advancements in the designs of filters and process technologies are further increasing their adoption among the life science industries.

In COVID-19 pandemic, there was an increased demand for vaccine manufacturing. The increased demand for vaccines and expansion of manufacturing capacities has led to higher demand for life science filtration devices and consequently filtration companies are expanded their production capacity of filters to meet the demand.

The life science filtration market is fragmented, the top 6 players occupied xx% of the market share and the remaining xx% of the market is occupied by other players. The major players in the life science filtration global market are 3M Company (U.S.), Asahi Kasei Corporation (Japan), Baxter International Inc. (U.S.), Danaher Corporation (U.S.), Fresenius SE & Co. KGaA (Germany), Merck KGaA (Germany), Nipro Corporation (Japan), Parker-Hannifin Corporation (U.S.), Repligen Corporation (U.S.), and Sartorius (Germany).